M-CSF serous rate evolution during post-transplantation days in a heterotopic heart graft model mice
Cornu, E.; Lacroix, P.; Virot, P.; Aldigier, J.C.; Praloran, P.; Christides, C.; Laskar, M.
Journal of Cardiovascular Surgery 38(6): 567-570
1997
ISSN/ISBN: 0021-9509 PMID: 9461259 Document Number: 482253
On heterotopic heart graft in mice, aged 7 weeks (C3H and B57), we investigate the variations of Macrophage Colony stimulating factor serous rate. The macrophage colony stimulating factor (M-CSF) is a cytokine involved in the immune response during transplantation. Five groups were determined, group 1 with a heterotopic transplant without immunosuppressive treatment (N=24); group 2 with a heterotopic transplant and Corticoid treatment after the graft (N=29); group 3 with a heterotopic transplant and cyclosporine treatment after the graft (N=34); group 4 with an isogenic transplant (N=31) and group 5 undergoing a laparotomy (N=31). The mice are sacrificed at D4, D7, D10 or D14 and the M-CSF dosage are done by ELISA method. The serous rate of M-CSF is stable in the group with an isogenic transplant or with only a laparotomy. But in the group with a heterotopic transplant the M-CSF values increase (x1.5). If we use an immunosuppressive treatment the raising of M-CSF is less important. When we have a rejection graft, the serous rate of M-CSF increases but not significantly (Mann-Whitney test). We conclude M-CSF seems to be a reliable index of disorder during immune response, but is not a good marker of the rejection.